These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28132981)

  • 21. [OCT analysis of in-stent neointima over 5 years post-DES implantation].
    Han Y; Yuan XH; Jiang MT; Feng HH; Zhang X; Zhang YQ; Jing J; Chen YD; Gao L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Feb; 52(2):150-157. PubMed ID: 38326066
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.
    Lee SJ; Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Clin Cardiol; 2011 Oct; 34(10):633-9. PubMed ID: 21928365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.
    Sato K; Costopoulos C; Takebayashi H; Naganuma T; Miyazaki T; Goto K; Yamane H; Hagikura A; Kikuta Y; Taniguchi M; Hiramatsu S; Ito H; Colombo A; Haruta S
    J Cardiol; 2014 Dec; 64(6):488-95. PubMed ID: 24794757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.
    Nishino M; Lee Y; Nakamura D; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    J Invasive Cardiol; 2012 Oct; 24(10):478-83. PubMed ID: 23043029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography.
    Goto K; Takebayashi H; Kihara Y; Hagikura A; Fujiwara Y; Kikuta Y; Sato K; Kodama S; Taniguchi M; Hiramatsu S; Haruta S
    EuroIntervention; 2013 Sep; 9(5):601-7. PubMed ID: 23518860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of post-stent irregular protrusion and subsequent neointimal characteristics between second- and third-generation drug-eluting stent implantation.
    Miura T; Sonoda S; Sanuki Y; Naka Y; Okabe H; Setoyama K; Inoue K; Shimizu A; Anai R; Tsuda Y; Araki M; Otsuji Y
    J Cardiol; 2020 Nov; 76(5):464-471. PubMed ID: 32636130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Qualitative and quantitative assessment of stent restenosis by optical coherence tomography: comparison between drug-eluting and bare-metal stents.
    Nagoshi R; Shinke T; Otake H; Shite J; Matsumoto D; Kawamori H; Nakagawa M; Kozuki A; Hariki H; Inoue T; Ohsue T; Taniguchi Y; Iwasaki M; Nishio R; Hiranuma N; Konishi A; Kinutani H; Miyoshi N; Takaya T; Yamada S; Yasaka Y; Hayashi T; Yokoyama M; Kato H; Kadotani M; Ohnishi Y; Hirata K
    Circ J; 2013; 77(3):652-60. PubMed ID: 23257388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of postintervention and nine-month luminal enlargement after treatment of drug-eluting in-stent restenosis with a drug-eluting balloon.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Am J Cardiol; 2014 May; 113(9):1468-73. PubMed ID: 24607028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
    Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
    Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Implication of Optical Coherence Tomography-Based Neoatherosclerosis.
    Hong SJ; Lee SY; Hong MK
    J Korean Med Sci; 2017 Jul; 32(7):1056-1061. PubMed ID: 28581259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents.
    Kilickesmez K; Dall'Ara G; Rama-Merchan JC; Ghione M; Mattesini A; Vinues CM; Konstantinidis N; Pighi M; Estevez-Loureiro R; Zivelonghi C; Lindsay AC; Secco GG; Foin N; De Silva R; Di Mario C
    Int J Cardiol Heart Vessel; 2014 Jun; 3():68-74. PubMed ID: 29450174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    J Interv Cardiol; 2017 Jun; 30(3):195-203. PubMed ID: 28295660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.
    Kim HO; Jung HW; Lee JH; Kim JS; Hong SJ; Ahn CM; Kim BK; Kim W; Kim SJ; Kim W; Ko YG; Choi D; Hong MK; Jang Y
    Coron Artery Dis; 2020 Dec; 31(8):694-702. PubMed ID: 32976245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
    Huang WC; Teng HI; Chen HY; Wu CJ; Tsai CT; Hsueh CH; Chen YY; Hau WK; Lu TM
    Int J Cardiol; 2019 Aug; 289():131-137. PubMed ID: 31079970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography.
    Takano M; Yamamoto M; Inami S; Murakami D; Ohba T; Seino Y; Mizuno K
    J Am Coll Cardiol; 2009 Dec; 55(1):26-32. PubMed ID: 20117359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography.
    Yonetsu T; Kim JS; Kato K; Kim SJ; Xing L; Yeh RW; Sakhuja R; McNulty I; Lee H; Zhang S; Uemura S; Yu B; Kakuta T; Jang IK
    Am J Cardiol; 2012 Oct; 110(7):933-9. PubMed ID: 22727183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naturally Occurring Atherosclerosis Progression and In-stent Restenosis: Exploring Histomorphologic Associations Using Optical Coherence Tomography.
    Zhang W; Zhang W; Gu N; Qiu Z; Pan L; Zhao Y; Shi B
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):646-654. PubMed ID: 38030142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.